Dr. Xiangyang Yu is a Program Manager at Accellient Partner. She was a principal investigator of medicinal chemistry at Ironwood Pharmaceuticals. She had been passionately involved in drug discovery programs in multiple therapeutical areas as well as efficiently and strategically managing external drug discovery collaborations in the US, Europe and Asia. Prior to joining Ironwood, Dr. Yu was Associate Director and then Director of Medicinal Chemistry at Epix Pharmaceuticals leading successful drug discovery programs. She was the project leader for S1P program licensed to Amgen for highly potent, selective and orally active agents for autoimmune diseases. Dr. Yu was also a project leader for GSK collaborative discovery program which resulted in multiple milestone payments. Before joining Epix, she led multiple anti-infectious programs at Activbiotics and Cubist Pharmaceuticals. Dr. Yu has critical scientific and management job skills including strategic alliances, leadership, inventorship and drafting of patents and publications. She has extensive experience in advance compounds from discovery screening to preclinical & clinical development. Dr. Yu obtained Ph.D. in Organic Chemistry from Florida State University. She received her undergraduate degree from East China University of Science & Technology in Shanghai, China. Dr. Yu was the President of Chinese American BioMedical Association (CABA) in 2013-2014 and is currently a Board Director of CABA.